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The metabolism of benzene is reviewed, and the objectives of a quantitative balance study begun
in 1945 are outlined; problems of toxicology and metabolism research of some 50 years ago are
considered. The quantitative metabolism of 14C-benzene in the rabbit is annotated and compared
with that of unlabeled benzene quantified by nonisotopic methods. The anomalies of phenylmer-
capturic acid and trans-trans-muconic acid as metabolites of benzene are examined in detail by
isotopic and nonisotopic methods; these compounds are true but minor metabolites of benzene.
Oxygen radicals are involved in both the metabolism of benzene and its toxicity; the roles of
CYP2E1, the redox cycling of quinone metabolites, glutathione oxidation, and oxidative stress in
the unique radiomimetic, hematopoietic toxicity of benzene are discussed. Differences between
the toxicity of benzene and the halobenzenes are related to fundamental differences in their
electronic structures and to the consequent pathways of metabolic activation and detoxication.
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Introduction
My first insight into benzene toxicity came
in the autumn of 1939 when, as a young
first-year medical student at University
College, London, I was sent to work on a
research project at Glaxo Laboratories,
Greenford, U.K. Glaxo had been given the
wartime task of manufacturing penicillin
and a host of other drugs and vitamins
needed for the war effort; in return they
had been given the services of numerous
science graduates who otherwise would
have been conscripted into the armed ser-
vices. In those days ofWorld War II, full-
time university students were exempt from
conscription but were encouraged to
undertake part-time war work in addition
to their studies; hence my casual employ-
ment at Glaxo, assisting the works' medical
officer to ascertain why so many of the
research workers were showing clinical
signs of scurvy. Ascorbate excretion and
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loading studies confirmed the vitamin C
deficiency; and it quickly became apparent
that this was associated with high exposure
to benzene, which was the major solvent
used in the various production lines. Open
vats containing 100 litres or more ofben-
zene solutions were moved around on
trolleys. Often the solvent was spilled, so
the concrete floors were awash with ben-
zene and the workers' clothes were soaked
in the solvent. In addition, benzene was
continuously being distilled in open sys-
tems to recover the solvent for further use,
and serious conflagrations were all too fre-
quent. Strangely, although it was well doc-
umented at that time that exposure to
benzene was associated with aplastic ane-
mia, none of the chemists employed con-
sidered that there was any health hazard in
their negligent use ofthis solvent.
When the exposure problems were
brought out, the Glaxo management acted
most expeditiously. Henceforth, benzene
solutions were contained in closed systems,
all exposed workers were given orange juice
and vitamin-reinforced milk drinks twice a
day; blood counts and urinary ascorbate
excretions were taken weekly; and, most
important ofall, alcohol, acetone, and other
solvents were used as alternatives to ben-
zene wherever possible. This was probably
one of the earliest uses of positive mea-
sures in industrial hygiene in the chemical
industry, occurring as it did more than 55
years ago. The study of oxygen radicals
and oxidative stress were very much in
vogue at the time, and the role ofascorbic
acid as an antioxidant was well recognized.
Furthermore, the radiomimetic character
ofbenzene toxicity indicated that, as with
ionizing radiation, oxygen radicals or reac-
tive oxygen species (ROS) were ultimately
involved, and that vitamin C was probably
a vital component ofthe biological defense
against ROS and benzene toxicity.
Nearly 10 years later, after graduating
in medicine and chemistry, and spending 4
years in the armed services, I made my
second contact with benzene, this time as a
research student with the late R.T.
Williams at St. Mary's Hospital Medical
School, London. Williams agreed that I
should study all the known pathways of
benzene metabolism, quantitatively and
simultaneously, so as to obtain a balance-
sheet ofthe metabolic fate ofthe chemical.
Benzene was chosen, not only because of
its known toxicity, but also because this
was to be the parent compound and a
model for more extensive programs of
metabolism ofa variety ofaromatic chemi-
cals. Furthermore, since benzene was known
to be a radiomimetic toxin, it was consid-
ered that knowledge ofits metabolism and
mechanism oftoxicity might reveal infor-
mation concerning the mechanism(s) of
radiation toxicity, a subject ofgreat interest
at that time, only 3 years after Hiroshima.
Our research objectives included the follow-
ing: a) to determine ifbenzene forms a mer-
capturic acid; b) to learn ifbenzene yields
cis-cisand cis-transisomers ofmuconic acid;
c) to discover ifbenzene forms an epoxide
or a dihydrodiol; d) to draw up a balance
sheet for benzene metabolism; e) to synthe-
size 14C-benzene and confirm the metabo-
lism balance sheet; f) to determine if
14C-benzene completely oxidized to 14C02;
and g) to learn ifits radiomimetic toxicity
makes benzene a suitable model compound
forstudyingbiological radiation damage.
Initial Problems and
Deficiencies
It is interesting today to reflect on how we
financed this research program, since in the
late 1940s almost no research grants were
available on either side of the Atlantic.
Consequently, there were almost no
research assistants and all academic staff,
including clinicians doing research, worked
at the bench and fed and cleaned their own
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experimental animals. The work week was
around 100 hr, with few free weekends and
only 2 weeks vacation a year; little wonder
that very few academics chose to undertake
research. Money for animals and supplies
came largely from commercial ventures,
such as the marketing of14C-labeled chem-
icals synthesized by us but surplus to our
requirements, marketing of 100% pure
chemicals made "in house," e.g., cysteine,
phenylglucuronide, and phenyl sulphate,
and initially-while the cost was high-the
recovery ofpenicillin from patients' urine
and purifying this for reuse. Instruments,
such as an ultraviolet (UV) spectropho-
tometer, a scintillation spectrometer for
quantification ofradioactive isotopes, and
chromatography equipment, were not
commercially available and had to be
designed and fabricated in our own labora-
tory; in several instances this resulted in the
establishment of new scientific instrument
companies and a diversity ofnew products.
Thus, these endeavors to meet research needs
by pioneering scientific innovation resulted
in successful commercial exploitation and
development ofseveral new industries.
A general problem that concerned us
from the outset ofthis research was how to
achieve and quantify chemical purity. The
only methods then available were fractional
recrystallization and distillation, and col-
umn chromatography on silica gel, alu-
mina, or partially activated charcoal. Few
purified solvents or chemical reagents were
available commercially; indeed, as subse-
quent work showed, most commercially
available chemicals were very crude mix-
tures. Benzene was purified by shaking
with sulfuric acid to remove thiophene,
then fractionally distilled and fractionally
crystallized but was still far from pure as
judged from melting-point studies and
from later studies with 14C-benzene when
that was finally prepared. Other chemicals,
especially the potential "metabolites of
benzene, namely, phenol, catechol, quinol
(hydroquinone), and hydroxyquinol (1,2,4-
trihydroxybenzene), were rigorously
purified before use by preparation ofderiv-
atives, recrystallization to constant melting
points, then hydrolyzed to regenerate the
original compounds, which were further
recrystallized to purity. In many cases the
physical constants of the highly purified
metabolites and their derivatives were
significantly different from those previ-
ously recorded in the literature; this was
particularly true where 14C-labeled com-
pounds had been synthesized and where
constant specific radioactivity was the
accepted criterion ofpurity. This gave rise
to the view, often expressed by British and
American chemists at that time, that the
physical constants ofaromatic compounds
characterized before 1950 were probably
incorrect and should be redetermined
using specific radioactivity as the criterion
of purity-an invitation that we firmly
resisted so that we could concentrate our
research efforts on the metabolism prob-
lems. Many years later, when we had
adopted gas-liquid chromatography as the
means ofpurification, with a symmetrical
peak in two systems as a criterion ofpurity,
we were amazed to receive a sample of14C-
cyclohexane from Amersham (Amersham,
U.K.) that contained not only 14C_cyclo_
hexene, 14C-cyclohexadiene, and 14C-ben-
zene, but also 36CI-chlorobenzene as
impurities. This discovery led to the real-
ization that coelution ofchemically similar
compounds could prejudice the use of gas
chromatography in purification proce-
dures. Initial studies at Oxford with gas
chromatography in the early 1960s showed
that commercially recrystallized phenol,
as used as a solvent for paper chromato-
graphy, was only some 60% pure, thus
explaining our earlier need for rigorous
purification of this benzene metabolite in
isotope dilution studies. This great difficulty
in obtaining pure compounds, i.e., 100%
pure, greatly affected this research pro-
gram, both in its inception and in the
methodology we chose. Radioisotope label-
ing now was considered essential for the
benzene metabolism study, and synthesis
of i4C-benzene was given high priority.
Unlabeled benzene, for nonisotopic metab-
olism studies, was purified by fractional
distillation, removal ofthiophene, followed
by fractional crystallization, and finally
purification as the clathrate complex, as
used in thepurification ofi4C-benzene.
Synthesis of 14C-Benzene
The only 14C-labeled material available in
the United Kingdom in 1948 was BaI4C2.
We planned to use Bai4C2to generate
14C2H2, then to pyrolyze this to 14C6H6
by passing through a red-hot tube, but the
very poor yields led us to consider alterna-
tive synthetic approaches. Eventually, we
concentrated our efforts on studying the
metabolism of benzene using unlabeled
material and left the radiosynthesis of14C-
benzene to our chemistry collaborators.
14C-Benzene with a single atom of14C
per moleculewas prepared eventuallybyring
closure ofcyclopentane-14C-carboxylic acid
to 14C-cyclohexane and dehydrogenation of
the latter with Pt/C (1). 14C-Benzene was
quantified by end-window counting ofthe
solid benzene-clathrate complex and
checked by end-window counting ofsolid
m-dinitrobenzene. The benzene-clathrate
complex was formed by shaking benzene
with a solution of nickel ammonium
cyanide cooled in ice; the solid complex
was filtered off, washed with water,
ethanol, and diethyl ether, and dried in air
(2). Dry distillation ofthe clathrate com-
plex gave pure benzene.
Determination ofthe specific radioac-
tivities of '4C-metabolites was carried out
by end-window counting, as liquid scintil-
lation spectrometry had not been developed
at that time. Indeed, researchers in the field
decided to abandon scintillation counting
because ofthe high background and lack of
specificity. However, the potential advan-
tages over end-window counting appeared
so substantial that we decided to continue
this line ofresearch and were fortunate to
find collaborators who, by the invention of
coincidence circuitry and voltage discrimi-
nators, finally constructed a prototype
Packard scintillation spectrometer. In sub-
sequent metabolism studies with 14C-
labeled compounds, we were able to use the
more specific, and more sensitive, scintilla-
tion spectrometry in place ofend-window
Geiger-Muller (GM) tube counting.
Benzene Eliminated
Unchanged
Benzene was quantified by a colorimetric
method based on trapping the exhaled ben-
zene in a nitrating mixture, extracting the
m-dinitrobenzene with methyl ethyl ketone,
shaking with alkali to develop a purple
color, and measurement ofthe light absorp-
tion in a Spekker absorptiometer using suit-
able light filters. The original method of
Pearce et al. (3) was modified to optimize
for sensitivity (4), which was 1 pg benzene
with an accuracy of± 5%.
Subsequently, when a variable wave-
length UV spectrophotometer had been
built, the benzene was trapped in ethanol,
then quantified spectrophotometrically in
the prototype Unicam SP500 (Cambridge
Instruments, Cambridge, U.K.) by measure-
ment ofthe absorption at 255.0 nm with a
slit width of 0.4 mm and an Emax of 240
(5). Also, when 14C-benzene had been syn-
thesized, a radiometric method was used; the
benzene was trapped in ethanol, converted
to the clathrate complex, then counted by
the end-window GM tube method.
The experimental animals were chin-
chilla rabbits (23 kg bw); they were dosed
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with benzene administered orally by gastric
intubation or by ip injection. The animals
were then placed in a Perspex chamber con-
nected to the appropriate absorption train,
and air was drawn through the system at 20
liters/hr for 20 to 30 hr. The absorption
train was changed every 2 hr.
Agreement among the three methods of
determination (colorimetric, spectrophoto-
metric, and radiometric) of unchanged
benzene was good (±10%). Elimination
unchanged by rabbits was maximal during
the first 12 hr after dosage and amounted
to about 40% per dose at dose levels of
0.25 and 0.5 g/kg and 64% at 1.0 g/kg
(4). The conclusions drawn from these
studies were that the rabbit can metabolize
benzene up to a limit of about 400
mg/kg/day and that with doses exceeding
this, the excess benzene is exhaled in the
expired air by a process similar to steam
distillation (4,6). Negligible amounts of
unchanged benzene (<0.01% dose) were
found in rabbit urine.
Metabolism to
L-Phenylmercapturic Acid
Phenylmercapturic acid, equivalent to 0.4%
dose, had been isolated from the urine of
rats dosed with benzene (7), but attempts
to repeat this in other laboratories had
failed. Furthermore, attempts to repeat the
synthesis ofL-phenylmercapturic acid (8)
also failed. As a result, in the late 1940s the
metabolism of benzene to phenylmercap-
turic acid was very much in doubt; indeed,
even the role of mercapturic acids in the
metabolism of other organic compounds
was in question. One ofthe reasons for this
was the failure ofother laboratories to syn-
thesize the phenylmercapturic acids as
described by Zbarsky and Young (8). An
investigation into the cause of this failure
showed that the definitive paper had been
erroneously altered by the journal editor,
for throughout the paper, HCI had been
changed to H2SO4 merely for the sake of
uniformity, yet the chloride anion had
been shown to be an essential catalyst for
the synthesis. Moreover, our commercial
cystine was grossly impure. As soon as
sodium chloride was added to the reaction
mixture and pure cystine was used, the var-
ious phenylmercapturic acids were synthe-
sized in good yield; the validity ofZbarsky
and Young's synthesis of the mercapturic
acids and oftheir occurrence as metabolites
ofaromatic compounds were confirmed.
The excretion of phenylmercapturic
acid in rabbit urine was quantified by the
iodometric method ofStekol (9) and by a
turbidimetric determination ofthe phenyl-
mercapturic mercaptide (10). The two
methods showed excellent agreement (±2%)
in the determination ofstandard amounts of
synthetic L-phenylmercapturic acid added to
rabbit urine, but the turbidimetric method
was the more specific andwas preferred over
the iodometric titration, which gave high
blankvalues with rabbit urine because ofthe
excretion ofdietary thiols. After dosing rab-
bits with benzene, the iodometric method
gave 1.8 ±0.2% dose as phenylmercapturic
acid at 0.5 g benzene/kg bw and 1.2 ±0.1%
at 1.0 g/kg; the turbidimetric method gave
1.0 ±0.1% and 0.8 ±0.1% as phenylmer-
capturic acid at doses ofbenzene of0.5 and
1.0 g/kg, respectively. Many attempts to iso-
late phenylmercapturic acid from the urine
ofrabbits dosed with benzene were unsuc-
cessful, and the only crystalline material so
obtained was benzoic acid.
Unequivocal proofofthe formation of
phenylmercapturic acid in the metabolism
of benzene was obtained by oral admin-
istration of 14C-benzene to rabbits. Reverse
isotope dilution studies with synthetic
L-phenylmercapturic acid gave material
which, after repeated recrystallization to
constant specific radioactivity, was equiva-
lent to 0.73% ofthe dose of14C-benzene.
Conversion ofthis material to phenylmer-
capturic mercaptide gave specific radioactiv-
ity equivalent to 0.70% dose and conversion
to thiophenol p-nitrobenzoate gave activity
equivalent to 0.74% dose. This figure of
0.7% dose from the radiobenzene study is
in close agreement with the figures of 0.8
and 1.0% dose from the turbidimetric
determination ofphenylmercapturic acid
formed from unlabeled benzene.
Metabolism to Muconic Acid
Muconic acid was first isolated as a
metabolite of benzene by Jaffe (11) from
the urine ofdogs and rabbits. Although it
was thought that if muconic acid were
formed by opening ofthe benzene ring in
vivo the cis-cis isomer should have been the
initial product-as is obtained by the in
vitro oxidative ring scission ofcatechol or
phenol with peracetic acid-only the trans-
trans isomer was isolated from the urine of
animals dosed with benzene (12). The
third geometric isomer of muconic acid,
namely, the cis-trans isomer, was first char-
acterized by Elvidge et al. (13) and was
formed merely by recrystallization of the
cis-cis isomer from water; in contrast, the
trans-trans acid was formed only after UV
irradiation ofa solution ofthe cis-cisisomer
in the presence ofiodine as catalyst.
The objectives of the 1945 to 1950
study were therefore a) to develop a quan-
titative methodology for determination of
each ofthe three isomers of muconic acid
in urine; b) to isolate and characterize each
isomer that was shown to be a metabolite
of benzene; c) to determine the in vitro
and in vivo stabilities of the three isomers
to obtain an insight into the mechanism of
formation ofmuconic acid from benzene;
and d) to quantify the muconic acid
isomers excreted after administration of
14C-benzene to rabbits.
A colorimetric method, based on con-
densation ofthe muconic acid with phenol
in the presence ofH2SO4 to give a red pig-
ment and soluble in ethanol, was developed
to quantify each ofthe three isomers; cis-cis
and cis-transisomers give maximal red color
when heated at 100°C for 6 hr; the trans-
trans isomer, however, requires heating at
1600C for 20 min. Hence, the cis acids can
be quantifiedwhen present in mixtures with
the trans-trans acid; recoveries ofall three
isomers from urine were 100 ± 10% (5,12).
cis-cis-Muconic acid added to rabbit urine
was recovered quantitatively as a mixture of
the cisacids; no trans-transacid was formed.
After ip injection ofeach ofthe three iso-
mers of muconic acid into rabbits and
quantification ofthe urinary excretion, the
trans-trans acid was excreted unchanged
equivalent to 52± 5% dose, the cis-cis acid
was excreted as cis acids, equivalent to
66± 5% dose, and the cis-trans acid as cis
acids equivalent to 55 ±5% dose; no trans-
trans acid was detected after injection of
either ofthe cis acids. Hence, no evidence
was found for isomerization ofthe cis acids
to the trans-trans acid in vivo; furthermore,
no evidence was found for selective loss of
the cis acids added to rabbit urine in vitro.
The quantitative method therefore indicates
that trans-trans-muconic acid is a true
metabolite ofbenzene in the rabbit, equiva-
lent to 0.5% dose (0.15-1.0%) (12).
Furthermore, dosing rabbits with phenol or
catechol also resulted in the urinary excre-
tion of trans-trans-muconic acid equivalent
to 0.5 and 1.4% dose, respectively (5). The
oxidative ring opening ofbenzene first gives
rise to cis-cis-muconaldehyde, which then
isomerizes to cis-trans- and trans-trans-
muconaldehyde; the latter is oxidized in
vivo to trans-trans-muconic acid, and this
may be the actual route offormation ofthis
paradoxical metabolite (14).
After oral dosing of benzene (7 g) to
four rabbits, continuous ether extraction of
the acidified urine gave 120 mg of crude
crystalline material equivalent to 1.2%
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dose, which was shown not to contain any
cis-cis- or cis-trans-muconic acid. Recrystal-
lization from ethanol gave the pure trans-
trans-muconic acid equivalent to 0.1%
dose ofbenzene, and this was further char-
acterized as the benzhydryl ester. Finally,
after administration of14C-benzene to rab-
bits, reverse isotope dilution studies showed
that trans-trans-muconic acid was excreted
in the urine equivalent to 1.3% ofthe dose.
cis-cis-Muconic acid had originally been
prepared in the 1930s by the oxidation of
phenol and catechol with dilute peracetic
acid using 100 vol hydrogen peroxide.
Twenty years later, because ofthe develop-
ment of rocket fuel technology, 98%
peroxide became available; therefore this
was used in the synthesis of cis-cis-muconic
acid from phenol to obtain increased yields.
To decrease the risk of explosion, small
amounts of reaction mixture (2 ml per-
acetic acid and 0.2 g phenol in 5 ml coni-
cal flasks) kept cool at 0°C were used with
apparent safety. This was laborious and, to
accelerate production, the individual vol-
umes of peracetic acid were increased to
5 ml, with a total of 250 ml. However,
temperature control was lost and a series
of explosions ensued that wrecked the
entire laboratory, so we reverted to the
smaller individual volumes ofreactant with
complete safety.
Metabolism to Phenols
Phenol, catechol, and quinol (hydro-
quinone) had long been recognized as
metabolites ofbenzene, but the oxidation
of benzene to resorcinol, hydroxyquinol
(1,2,4-trihydroxybenzene) and other trihy-
dric phenols was uncertain. Attempts to
devise specific colorimetric or spectrophoto-
metric assays for the individual phenols all
failed because of the interference of other
phenols. Quantification of the individual
phenolic metabolites ofbenzene was there-
fore dependent on the administration of
14C-benzene, followed by reverse isotope
dilution ofthe urines with a number ofphe-
nols and purification ofcrystalline deriva-
tives. Phenol (23% dose) quinol (5%),
catechol (3%), and hydroxyquinol (0.3%)
were the major phenols resent in the urines
ofrabbits dosed with 1 C-benzene; resorci-
nol, if present, was formed only in trace
amounts (<0.3% dose), and phloroglucinol
and pyrogallol were absent. The dihydrodiol
of chlorobenzene had been isolated from
rabbit urine at that time (15), so a similar
isolation procedure was carried out on the
urine of rabbits given 14C-benzene. No
dihydrodiol was ever detected. Nevertheless,
it was presumed that the phenols had been
formed by the dehydration of the corre-
sponding diols, so that resorcinol and
phloroglucinol were considered unlikely
metabolites. Pyrogallol could have been a
trace metabolite but was not detected, possi-
bly because of polymerization of the
quinone oxidation products, a process that
may have led to low values for catechol,
quinol, and hydroxyquinol despite the
various precautions.
Determination oftotal conjugates in the
urine ofrabbits dosed with unlabeled ben-
zene was the only approximation that could
be made ofthe total phenols formed from
unlabeled benzene. The total glucuronides
were equivalent to 11% dose, and the ethe-
real sulfates were equivalent to 25% dose, a
total of36% (Table 1). This compares with
a total of 31% being excreted as phenol,
quinol, catechol, and hydroxyquinol in
14C-benzene urine. This lower total might
be due to the formation of bisconjugates of
quinol, catechol, orhydroxyquinol.
Metabolism of 14C-Benzene
As seen (Table 1), the quantitative balance
sheet for the metabolism ofunlabeled ben-
zene is in good agreement with the more
detailed picture obtained by dosing with
14C-benzene (16). The totals in the expired
air (47.5, 48.4%) and totals excreted in the
urines (33, 38%) for the labeled and unla-
beled benzenes are in excellent agreement.
Evidence was obtained that 14C-benzene
could be oxidized completely to 14C02 (1%
dose), and consequently 14C was incorpo-
rated into the body tissues to the extent of
at least 5% dose. Indeed, it is most likely
Table 1. Metabolism of14C-benzene in rabbit.
Unlabeled
Source 14C-Benzene benzene
Expired air
Benzene 46.5 48.4
14CO2 1.0 -
Total in expired air 47.5% 48.4%
Urine
Phenol 22.9a
Catechol 2.9a
Quinol 4.8a
Resorcinol < 0.3a
Hydroxyquinol 0.3a
L-Phenylmercapturic acid 0.4 1.0
trans-trans-Muconic acid 1.3 1.0
Total in urine 32.9% 38%
Feces 0.5% -
Tissues ca 5% -
Total accounted for 86% 86%
a25 as ethereal sulfates; 1 1 as glucuronides. Data
from Parke and Williams (4,10,12,16) and Parke (5).
that the shortfall ofsome 15% dose in the
overall balance sheet could be due to incor-
poration ofthe isotope 14C into aliphatic
carboxylic acids, formed as the result of
oxidative ring scission, and the subsequent
biosynthesis of these fatty acids into tissue
components. In one rabbit experiment
when 14C-benzene was administered, the
total residual radioactivity remaining in
all of the tissues 48 hr after dosing was
equivalent to some 16% dose (5).
Benzene and Oxygen Radicals
The known radiomimetic toxicity of
benzene suggested, even some 50 years ago,
that this solvent gives rise to the produc-
tion ofoxygen radicals ROS. Diethyl ether
administered to rats also results in ROS
production, glutathione depletion, and
oxidative stress (17,18), for both diethyl
ether and benzene activate the ROS-gener-
ating cytochrome P450, CYP2E1 (19) and
can thus result in oxidative stress in vivo.
However, benzene also generates ROS by
the redox cycling of its quinone metabo-
lites, which may explain the unique radio-
mimetic, hematopoietic toxicity of
benzene, as CYP2E1 is not dominant in
the bone marrow whereas myeloperoxidase
is. Sources ofROS are as follows: a) ioniz-
ing radiation; b) iron and other redox
metals; c) inflammation: activated leuko-
cytes, infections, interleukins; d) eicosanoid
biosynthesis (prostaglandin H synthase
activity); e) redox cycling of quinones;
f) futile cycling of cytochromes P450:
P450-activated 02 is partly inserted as ROS
into the substrate and partly released as
superoxide, etc.; and g) activation of
CYP2E1: 02 activation to ROS is preferred
to the direct insertion ofoxygen into the
substrate. Bone-marrow phagocytes play a
major role in benzene-induced hemotoxic-
ity, and exposure ofmice to benzene results
in the activation of the phagocytes with
increased ROS production, changed bone
marrow progenitor-cell development, and
increased production ofinterleukins (IL-1)
and tumor necrosis factor (TNFa) (20,21).
Induction of CYP2E1 by benzene,
ether, ethanol, acetone, and a variety of
other small molecules, or by fasting,
increases the metabolism of benzene and
phenol to quinol and other myelotoxic
metabolites (22) and also increases ROS
production. ROS, from whatever origin,
are the means ofthe metabolic activation of
benzene and are the source of its toxicity,
causing depletion ofglutathione (GSH),
oxidative stress, DNA damage, activation
of protein kinase c, tissue necrosis, and
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malignancy (23). The metabolic activation
ofbenzene and the generation of ROS by
CYP2E1 might be genetically dependent
and polymorphic, as is the metabolism of
ethanol by this cytochrome (24), so that
benzene toxicity would show individual
variation. Prostaglandin H synthase activ-
ity similarly metabolically activates benzene
and phenol to toxic reactive intermediates,
and consequently indomethacin inhibits
benzene-induced bone-marrow toxicity
(25). Myeloperoxidase in bone marrow
also hydroxylates benzene to quinol and
other reactive metabolites by generation of
singlet oxygen (26).
The synergism ofcatechol and quinol
in benzene-induced toxicity and leukemia
(27) could involve a concerted action of
redox cycling of quinol, generating ROS
and thereby hydroxylating catechol to
hydroxyquinol (benzene 1,2,4-triol). This
would be followed by further redox cycling
ofhydroxyquinol, further ROS generation,
interaction with GSH to form 2,5-dihy-
droxyphenylmercapturic acid (28), with
consequent damage to hemopoietic tissues
(29), and malignancy.
This generation ofROS from CYP2E1,
redox cycling of the quinones, and other
mechanisms have been shown in the case
ofether anesthesia (17,18) to result in loss
of GSH, oxidative stress, tissue inflamma-
tion and tissue necrosis (Figure 1), which
may lead to chronic inflammatory disease
such as rheumatoid arthritis, inflammatory
bowel disease, atherosclerosis, multiple sys-
tem organ failure, and malignancy (30,31).
Many chemicals, particularly substrates
of CYP2E1 such as halothane and ether,
initiate immune or inflammatory responses
associated with ROS production and GSH
depletion and are associated with many
syndromes ofchronic inflammation (30).
Thus it is possible that benzene exposure
may likewise be associated with various
manifestations of systemic inflammation
in addition to the known myelotoxicity and
malignancy. Protection against ROS and
oxidative stress is given by intracellular GSH
and bydietary ascorbic acid, tocopherol, and
otherradical-trapping antioxidants (30).
Conclusions
It has long been known that the unique
radiomimetic myelotoxicity of benzene is
associated with its metabolism and that the
difference in toxicity between benzene and
the halobenzenes is associated with funda-
mental differences in their metabolic fates
(32). Whereas the hepatotoxic chloroben-
zene and bromobenzene are oxidized by
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Figure 1. Mechanisms of oxidative stress and tissue inflammation. ROS are generated from cytochrome P4502E1
(CYP2E1), stimulated by exposure to benzene, ether, and other small molecules, and by fasting. The ROS oxidize
intracellular GSH to GSSG, which is lost from the cell unless GSH is regenerated by glutathione reductase plus
NADPH. Loss of GSH and other antioxidants (TRAP = total radical antioxidant parameter = tocopherols, ascorbic
acid, retinoids, etc.) results in oxidative stress, lipid peroxidation, release of interleukins (IL-6), leukotrienes (LTB4),
platelet-activating factor (PAF), etc. This, in turn, leads to leukocyte activation and migration into tissues, with
generation of further ROS, depletion of GSH and TRAP, resulting in surgical shock and multiple system organ fail-
ure (MSOF). Hence, exposure to benzene might result in conditions associated with chronic systemic inflammation.
various cytochromes P450 to form a
relatively stable 3,4-epoxide that yields the
corresponding dihydrodiol, catechol, and
mercapturic acid as the major metabolites
(15), the myelotoxic, leukemogenic ben-
zene is oxidized by ROS from CYP2E1 to
yield a metastable radical that rearranges to
form phenol as the major metabolite, with
only traces ofcatechol (3%) and phenyl-
mercapturic acid (1%). Deactivation of
the aromatic ring by the halogen sub-
stituent thus facilitates the insertion of an
activated oxygen from a cytochrome
P450, and this allows epoxidation and
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consequent metabolic detoxication. By
contrast, benzene appears to be metabo-
lized with difficulty; and as with ethanol,
diethyl ether, carbon tetrachloride, ace-
tone, and many other small molecules that
are resistant to oxidative metabolism by the
cytochromes P450, it is metabolized by
CYP2E1 by generating ROS. The ROS
also mediate malignancy and form quinones
that undergo redox cycling to generate
ROS in bone marrow, mediating myelo-
toxicity (19,25). The identification of
other CYP2E1 substrates that are likely to
manifest myelotoxicity and malignancy is
now well advanced and depends on deter-
mination of the molecular diameter ofthe
chemical and ofthe energies ofthe molec-
ular orbitals (23,33). Thus, our knowledge
of benzene metabolism and toxicity has
continued to evolve over more than 50
years and is now enabling the prediction
ofchemicals with similar toxicity.
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